COVID-19 & CancerFree IL-6 antagonists may have a role in fighting COVID-19 after all September 25, 2020Vol.46 No.36By Paul Goldberg
COVID-19 & CancerFree Francis Collins: “We’ve just got to get this done. Because people are dying and time is passing.” September 18, 2020Vol.46 No.35By Alexandria Carolan
Conversation with The Cancer LetterCOVID-19 & CancerFree John Carpten: Inaugural AACR report calls for legislative action on disparate burden of cancer September 18, 2020Vol.46 No.35By Matthew Bin Han Ong
Conversation with The Cancer LetterCOVID-19 & CancerFree Barry Sleckman reflects on difficult months in Birmingham September 18, 2020Vol.46 No.35By Paul Goldberg
COVID-19 & CancerFreeGuest Editorial HOLA COVID-19 study focuses on disruption of cancer care in Latin America September 18, 2020Vol.46 No.35By Carolina Bernabe, Ana I. Velázquez Mañana, Coral Olazagasti and Narjust Florez
COVID-19 & CancerFreeGuest Editorial Seeing COVID-19 through a cloud of cigarette smoke September 18, 2020Vol.46 No.35By Alan Blum and Eric Solberg
COVID-19 & CancerFreeGuest Editorial COVID-19 threatens to increase cancer mortality September 18, 2020Vol.46 No.35By Shelley A. DuBois and Raymond N. DuBois
NCI will form an ad hoc committee to review screening trialsThe future of ECOG-ACRIN's slowly-accruing TMIST is in question September 11, 2020Vol.46 No.34By Paul Goldberg
FreeGuest Editorial An open letter to Sen. Kamala Harris September 11, 2020Vol.46 No.34By Hooman Noorchashm
Letter To The Editor A reminder: The real goal is saving lives September 11, 2020Vol.46 No.34By Frances M. Visco
